Antonio Regazzoli

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Giuseppe Rossi

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Marinella Calarco

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Francesco Castelli

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Elena Gobbi

Istituti di Ricovero e Cura a Carattere Scientifico

Arianna Gatti

Azienda Ospedaliera Ospedale Civile di Legnano

Virginia Catinella

Ospedale di Santo Spirito

Virginia Ottaviano

University of Pisa

Giorgia Pantano

Policlinico Universitario di Catania

Vania Spinoni

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Mario Motta

Azienda USL di Bologna

Cooperative Institutions

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

University of Brescia

Istituti di Ricovero e Cura a Carattere Scientifico

Brescia University

University of Milan

University of Bologna

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Policlinico Universitario di Catania

University of Turin

University of Verona

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

P. falciparum malaria recrudescence in a cancer patient.

PubMed (2009)

Emanuele Focà Roberto Zulli F. Buelli M. Vecchi Antonio Regazzoli

Persons living for long periods of time in malaria hyper-endemic areas may suffer from hyper-reactive malarial splenomegaly (HMS), a frequent cause of splenomegaly in such areas. Splenomegaly and sub-microscopic P. falciparum parasitaemia are hallmarks of HMS. Spleen has been suggested to play a protective antimalarial role and splenectomy may trigger symptomatic malaria attacks. Other causes of immune suppression may possibly reactivate latent malaria parasites. We report the case of an Italian 60-year-old male, who had spent 33 years in sub-Saharan Africa, who experienced a P. falciparum malaria attack 12 months after his return to Italy, concomitantly with a diagnosis of lung carcinoma possibly impairing his immune system.

Severe Malaria

Source

Cite

Citations (13)

The Outcome of Different Types of Second-Line Therapy in Multiple Myeloma Patients Relapsing After Uniform Front-Line Treatment with High-Dose Melphalan and Autologous Stem Cell Transplantation.

Blood (2009)

Claudia Crippa Samantha Ferrari Monica Drera Marinella Calarco Antonio Regazzoli

Melphalan

Autologous stem-cell transplantation

Regimen

Salvage therapy

10.1182/blood.v114.22.2892.2892

Cite

Citations (0)

Pseudo-Gaucher plasma cells in the bone marrow of a patient with monoclonal gammopathy of undetermined significance.

PubMed (1998)

Antonio Regazzoli Alessandro Pozzi Giuseppe Rossi

Monoclonal gammopathy

Bone Marrow Diseases

Source

Cite

Citations (9)

Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study

Annals of Hematology (2019)

Elisa Cannizzo Maddalena Raia Maria Stefania De Propris Anna Triolo Barbara Scarpati

Paroxysmal nocturnal hemoglobinuria

Hemoglobinuria

clone (Java method)

Hematology

Bone marrow failure

10.1007/s00277-019-03644-8

Cite

Citations (12)

Congenital Plasmodium vivax malaria mimicking neonatal sepsis: a case report

Malaria Journal (2010)

Veronica Del Punta Maurizio Gulletta Alberto Matteelli Vania Spinoni Antonio Regazzoli

Although malaria in pregnancy can cause very significant neonatal morbidity, congenital malaria is a very rare condition in both endemic and non-endemic areas. A case of congenital malaria by Plasmodium vivax, initially mistaken for neonatal sepsis, is described. The correct diagnosis was accidentally done, as congenital malaria had been missed in the initial differential diagnosis. Vivax malaria is the leading species in congenital infections in Europe. This condition should be included in the differential diagnosis of neonatal sepsis even if the mother has no proven malarial episodes during the gestational period.

Neonatal Sepsis

Tropical Medicine

10.1186/1475-2875-9-63

Cite

Citations (35)

Re-treatment with rituximab in ANCA-associated vasculitis only in the presence of clinical relapse: A single centre experience

La Presse Médicale (2013)

Guido Jeannin Chiara Salviani Stefano Possenti Antonio Regazzoli Flavio Allegri

Microscopic polyangiitis

Proteinase 3

Granulomatosis with polyangiitis

Systemic vasculitis

10.1016/j.lpm.2013.02.295

Cite

Citations (0)

An Analysis of the Incidence, Risk Factors and Prognosis of Acute Promyelocytic Leukemia Following Mitoxantrone Therapy in Patients Affected by Multiple Sclerosis.

Blood (2006)

Chiara Cattaneo Erika Borlenghi Cinzia Cordioli Samantha Ferrari Antonio Regazzoli

Mitoxantrone

Cumulative incidence

Cumulative dose

10.1182/blood.v108.11.4488.4488

Cite

Citations (1)

Diagnostic accuracy and prognostic value of the CD64 index in very low birth weight neonates as a marker of early-onset sepsis

Scandinavian Journal of Infectious Diseases (2014)

Mario Motta Alice Zini Antonio Regazzoli Elena Garzoli G Chirico

Objective: To assess the diagnostic and prognostic utility of CD64 expression as a marker of early-onset sepsis (EOS) in very low birth weight (VLBW) neonates. Methods: Neutrophil CD64 expression (CD64 index) was assessed in 129 VLBW neonates within 72 h after birth. The accuracy of the CD64 index in predicting EOS was determined by receiver operating characteristic curve analysis. The relationship between the expression of the CD64 index and neonatal outcomes was evaluated by multivariate analysis. Results: The highest performance of the CD64 index was achieved at 24 h after birth; accuracy, sensitivity, and negative predictive values were 0.85, 0.89, and 0.99, respectively, with a cut-off value of 2.4. The increased expression of CD64 index was significantly associated with subsequent infections (relative risk 1.54; 95% confidence interval 1.02–2.33). Conclusions: The CD64 index could be used as a reliable marker of EOS in VLBW neonates and it is an independent risk factor for late-onset infections.

CD64

Neonatal Sepsis

10.3109/00365548.2014.896028

Cite

Citations (13)